Summary
- Current Price
- As of today, CTKB price is $4.94, up +3.35% on
- Current Price All-Time High
- CTKB price is currently -82.79% below its historical high of $28.70 set on
- Market Cap
- CTKB current market cap is $638M, up +36.87% over the past 365 days
- PE Ratio
- CTKB PE ratio is unknown
- Revenue
- CTKB current annual revenue is $201.49M, up +0.52% year-over-year
- Next Earnings
- The next earnings release for CTKB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cytek Biosciences, Inc. |
| Ticker | NASDAQ: CTKB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cytekbio.com |
| Employees | 663 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.94 | |
| Price, 1D Change | +3.35% | |
| $638M | ||
| - | ||
| - | ||
| 1.73 | ||
| $201M | ||
| Revenue, 1Y Change | +0.52% | |
| -$0.52 | ||
| EPS, 1Y Change | -1,029.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.52 | ||
| EPS Estimate | N/A | -$0.13 |
| EPS Est. Change | N/A | +75.04% |
| $201.49M | ||
| Revenue Estimate | N/A | $208.17M |
| Revenue Est. Change | N/A | +3.32% |
| Current Price | $4.94 | |
| Price Target | - | $5.75 |
| Price Tgt. Change | - | +16.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.15 | -$0.05 | -131.42% | |
| $0.02 | -$0.52 | -3,572.67% | |
| -$0.13 | N/A | +75.04% | |
| $0.06 | N/A | +111.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $202.96M | $200.45M | -1.23% | |
| $196.87M | $201.49M | +2.35% | |
| $208.17M | N/A | +3.32% | |
| $222.72M | N/A | +10.54% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.94 | |
| $4.46 | ||
| SMA 200 vs Price | -9.68% | |
| $4.47 | ||
| SMA 50 vs Price | -9.43% | |
| 1.73 | ||
| $0.21 | ||
| 64.41 | ||
| 58.06% | ||
| 65.01% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $201.49M | ||
| -$0.52 | ||
| $0.00 | ||
| 51.84% | ||
| -$40.38M | ||
| -20.04% | ||
| -$66.54M | ||
| -33.02% | ||
| -$28.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.10 | ||
| 5.04 | ||
| 4.42 | ||
| - | ||
| 3 | ||
| 4.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.17 | ||
| 1.87 | ||
| -14.36 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $341.74M | ||
| $261.53M | ||
| $461.54M | ||
| $392.00M | ||
| $119.80M | ||
| $77.80M | ||
| $33.02M | ||
| $11.67M | ||
| $6.41M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $268.03M | ||
| $144.84M | ||
| $97.03M | ||
| $108.38M | ||
| $11.98M | ||
| $0.00 | ||
| $36.70M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$4.69M | ||
| $10.12M | ||
| -$13.43M | ||
| $4.19M | ||
| -$8.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Stephens & Co. | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with CTKB
FAQ
What is the ticker symbol for Cytek Biosciences, Inc.?
The ticker symbol for Cytek Biosciences, Inc. is NASDAQ:CTKB
Does Cytek Biosciences, Inc. pay dividends?
No, Cytek Biosciences, Inc. does not pay dividends
What sector is Cytek Biosciences, Inc. in?
Cytek Biosciences, Inc. is in the Healthcare sector
What industry is Cytek Biosciences, Inc. in?
Cytek Biosciences, Inc. is in the Medical Devices industry
What country is Cytek Biosciences, Inc. based in?
Cytek Biosciences, Inc. is headquartered in United States
When did Cytek Biosciences, Inc. go public?
Cytek Biosciences, Inc. initial public offering (IPO) was on July 23, 2021
Is Cytek Biosciences, Inc. in the S&P 500?
No, Cytek Biosciences, Inc. is not included in the S&P 500 index
Is Cytek Biosciences, Inc. in the NASDAQ 100?
No, Cytek Biosciences, Inc. is not included in the NASDAQ 100 index
Is Cytek Biosciences, Inc. in the Dow Jones?
No, Cytek Biosciences, Inc. is not included in the Dow Jones index
When was Cytek Biosciences, Inc. last earnings report?
Cytek Biosciences, Inc.'s most recent earnings report was on February 26, 2026
When does Cytek Biosciences, Inc. report earnings?
The next expected earnings date for Cytek Biosciences, Inc. is May 7, 2026
Data Sources & References
- CTKB Official Website cytekbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831915/000162828026012352/0001628280-26-012352-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831915/000162828026012352/0001628280-26-012352-index.htm
- CTKB Profile on Yahoo Finance finance.yahoo.com/quote/CTKB
- CTKB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctkb